Skip to main content
. Author manuscript; available in PMC: 2008 Mar 31.
Published in final edited form as: JAMA. 2008 Feb 27;299(8):901–913. doi: 10.1001/jama.299.8.901

Table 7.

Change in Weight, Blood Pressure, Heart Rate, and Corrected QT Interval by Medication

Mean (SD) [95% Confidence Interval]
Baseline Week 12
Venlafaxine
   Weight, kg 68.9 (19.7) [65.7–71.9] 70.7 (20.1) [66.9–74.3]

   Diastolic blood pressure, mm Hga 67.0 (8.8) [65.6–68.4] 70.3 (8.5) [68.8–71.9]

   Systolic blood pressure, mm Hg 112.3 (14.0) [110.1–114.5] 115.5 (13.6) [113.0–118.0]

   Heart rate, beats/minb 76.3 (11.9) [74.4–78.1] 82.3 (12.5) [80.0–84.6]

   Corrected QT interval, ms 412.7 (21.4) [409.4–416.1] 410.3 (21.3) [406.3–414.3]

Selective serotonin reuptake inhibitor
   Weight, kg 69.5 (19.8) [66.3–72.5] 72.4 (20.4) [68.6–76.1]

   Diastolic blood pressure, mm Hg 66.3 (9.1) [64.9–67.7] 64.7 (10.2) [62.9–66.6]

   Systolic blood pressure, mm Hg 111.1 (13.1) [109.0–113.1] 111.5 (13.3) [109.1–113.9]

   Heart rate, beats/min 77.6 (12.4) [75.6–79.5] 77.5 (11.4) [75.4–79.6]

   Corrected QT interval, ms 413.9 (18.4) [411.1–416.8] 413.5 (17.0) [410.3–416.6]
a

Venlafaxine vs selective serotonin reuptake inhibitor: t = 2.88; P = .004.

b

Venlafaxine vs selective serotonin reuptake inhibitor: t = 3.41; P = .001.